{"id":"W3130535105","doi":"10.1016/j.urology.2020.11.080","title":"A Population-based Study Comparing Outcomes for Patients With Metastatic Castrate Resistant Prostate Cancer Treated by Urologists or Medical Oncologists With First Line Abiraterone Acetate or Enzalutamide","year":2021,"lang":"en","type":"article","venue":"Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Astellas Pharma Canada; Princess Margaret Cancer Foundation; Merck; Janssen Pharmaceuticals; Bayer","keywords":"Medicine; Enzalutamide; Abiraterone acetate; Prostate cancer; Hazard ratio; Internal medicine; Population; Abiraterone; Retrospective cohort study; Cohort; Proportional hazards model; Medical record; Cancer; Oncology; Androgen deprivation therapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002863723,0.0004162442,0.001090619,0.0001205783,0.0002333727,0.00004168322,0.0001456946,0.0001269172,0.0002919416],"category_scores_gemma":[0.000397398,0.0002075571,0.00006317947,0.0004372918,0.0002263861,0.00007490616,0.00005570365,0.000311679,0.000004670273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003110773,"about_ca_system_score_gemma":0.001460112,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001145041,"about_ca_topic_score_gemma":0.0524876,"domain_scores_codex":[0.9969804,0.0002632194,0.0005684376,0.0007680853,0.0006601089,0.0007597067],"domain_scores_gemma":[0.9978045,0.0007313642,0.0002416117,0.000388579,0.0004977501,0.0003362124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07563604,0.003076444,0.9155763,0.0002281173,0.00103925,0.002537507,0.0002221399,0.0008294953,0.00003625844,0.000001603041,0.0002008912,0.0006159606],"study_design_scores_gemma":[0.06436992,0.03452927,0.895764,0.000118403,0.001210373,0.00004235074,0.0001373171,0.002302527,0.000327391,0.000007747813,0.0008167329,0.0003740058],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907597,0.0002877693,0.0001584961,0.005215131,0.00007499158,0.00309418,0.0002908653,0.0001021352,0.00001679022],"genre_scores_gemma":[0.9942263,0.00008613412,0.0004409171,0.0008110511,0.00002713567,0.001439354,0.001170524,0.0000674086,0.001731152],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05134255,"threshold_uncertainty_score":0.964802,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05308431478800026,"score_gpt":0.3638635605801991,"score_spread":0.3107792457921989,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}